| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |